Texas Attorney General Takes Legal Action Against Acetaminophen Makers Regarding Autism Assertions

Texas Attorney General Ken Paxton is suing the producers of acetaminophen, alleging the companies hid alleged dangers that the medication posed to pediatric cognitive development.

The lawsuit comes thirty days after President Donald Trump promoted an unverified association between taking acetaminophen - referred to as paracetamol - during pregnancy and autism in young ones.

Paxton is taking legal action against Johnson & Johnson, which previously sold the medication, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "misled consumers by gaining financially from pain and marketing drugs without regard for the dangers."

The manufacturer states there is insufficient reliable data tying acetaminophen to autism.

"These corporations deceived for years, knowingly endangering numerous people to boost earnings," Paxton, from the Republican party, stated.

The company commented that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its online platform, Kenvue also mentioned it had "consistently assessed the pertinent research and there is lacking reliable evidence that demonstrates a established connection between taking acetaminophen and autism."

Associations representing physicians and medical practitioners share this view.

The leading OB-GYN organization has stated paracetamol - the primary component in Tylenol - is among limited choices for women during pregnancy to treat pain and fever, which can create serious health risks if not addressed.

"In multiple decades of research on the use of paracetamol in gestation, zero credible investigations has conclusively proven that the usage of acetaminophen in any period of pregnancy results in neurological conditions in young ones," the association said.

The lawsuit references recent announcements from the former administration in asserting the drug is reportedly hazardous.

In recent weeks, the former president generated worry from medical authorities when he advised pregnant women to "struggle intensely" not to use Tylenol when unwell.

Federal regulators then published an announcement that physicians should contemplate reducing the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in minors has not been proven.

Health Secretary RFK Jr, who manages the Food and Drug Administration, had pledged in spring to undertake "comprehensive study program" that would identify the origin of autism spectrum disorder in a short period.

But experts cautioned that discovering a sole reason of autism spectrum disorder - considered by experts to be the consequence of a complex mix of inherited and external influences - would prove challenging.

Autism spectrum disorder is a form of permanent neurological difference and disability that impacts how individuals experience and engage with the surroundings, and is identified using doctors' observations.

In his legal document, Paxton - aligned with the former president who is campaigning for federal office - claims Kenvue and J&J "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The case attempts to require the firms "eliminate any marketing or advertising" that asserts Tylenol is safe for expectant mothers.

This legal action mirrors the grievances of a assembly of guardians of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in recently.

A federal judge threw out the lawsuit, declaring studies from the plaintiffs' authorities was lacking definitive proof.